Ergomed (ERGO)

 

Latest News

Broker Forecast - Numis issues a broker note on Ergomed Plc

Numis today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and raised its price target to 300p (from 2...

Ergomed's PeproStat reports positive results

Ergomed has announced positive top-line results from its phase II clinical trial of PeproStat, the company's potential first-in...

Ergomed's PeproStat reports positive results

Miscellaneous medium priority announcements

Holding(s) in Company

Notification of major interests in shares

All News

DateHeadlineSource
23-10-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
23-10-17Ergomed's PeproStat reports positive resultsStockMarketWire
23-10-17Ergomed's PeproStat reports positive resultsRNS
12-10-17Holding(s) in CompanyRNS
06-10-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
03-10-17Ergomed completes acquisition of PSR StockMarketWire
03-10-17Completion of Acquisition of PSR Group BVRNS
28-09-17Ergomed conditionally raises £2.9mStockMarketWire
28-09-17Result of PlacingRNS
28-09-17Acquisition of PSR Group BV and PlacingRNS
27-09-17Commercialisation Deal on Haemostatix ProductsRNS
18-09-17Ergomed net service revenues up 53%StockMarketWire
18-09-17Interim ResultsRNS
21-08-17CEL-SCI Corporation issues restricted sharesRNS
14-08-17Ergomed's partner to resume Phase 3 study of MultikineStockMarketWire
14-08-17FDA removal of hold on Ph3 trial with MultikineRNS
14-08-17Ergomed schedules interim results StockMarketWire
14-08-17Notice of ResultsRNS
24-07-17Ergomed completes study recruitment ahead of schedule StockMarketWire
24-07-17Recruitment complete early for Phase IIb studyRNS
04-07-17Investor MeetingRNS
21-06-17PeproStat study passes recruitment mid-pointRNS
19-06-17Ergomed resolutions passed at AGMStockMarketWire
16-06-17Result of AGMRNS
16-06-17Ergomed appoints CEOStockMarketWire
16-06-17Appointment of CEORNS
13-06-17Ergomed to present at the Shares Spotlight Evening in Manchester on 29 June 2017StockMarketWire
22-05-17Appointment of N+1 Singer as joint brokerRNS
12-05-17Annual Report and Notice of AGMRNS
08-05-17Ergomed updates in PharmInvent earn-outStockMarketWire
08-05-17Issue of Shares to Former PharmInvent ShareholdersRNS
02-05-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
02-05-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
02-05-17Co-Development Partner NewsRNS
26-04-1711 shares where positive earnings shocks could trigger ralliesInteractive Investor
13-04-17Board and Management ChangesRNS
04-04-17Director Deals - Ergomed Plc (ERGO)StockMarketWire
04-04-17Director/PDMR ShareholdingRNS
03-04-17Ergomed partner announces successful dataStockMarketWire
03-04-17Partner Asarina Pharma announces successful dataRNS

RSS feeds

  • Editorial news feed for LSE:ERGO Editorial
  • Regulatory news feed for LSE:ERGO Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account